Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
EMA guidance · 2025-10-21EMA partners with content creators to promote safe and responsible use of GLP-1 medicines
EMA partners with content creators to promote safe and responsible use of GLP-1 medicines through the HealthNotHype campaign, expanding reac…
-
EMA guidance · 2024-06-26EU actions to tackle shortages of GLP-1 receptor agonists
EMA outlines recommendations from the Multi-Stakeholder Supply Group (MSSG) and actions to address shortages of GLP-1 receptor agonists in t…
-
EMA guidance · 2019-12-06EMA update on metformin diabetes medicines
EMA provides an update on metformin-containing diabetes medicines, outlining current assessments and recommendations related to safety and u…
-
EMA guidance · 2016-02-26EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes
EMA confirms recommendations to minimize risk of ketoacidosis associated with SGLT2 inhibitors used for diabetes management.
-
EMA guidance · 2016-02-12SGLT2 inhibitors: PRAC makes recommendations to minimise risk of diabetic ketoacidosis
PRAC recommends measures to minimize the risk of diabetic ketoacidosis with SGLT2 inhibitors.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.